Author's posts
Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market
Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.
Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.